http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106728453-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-185 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-285 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 |
| filingDate | 2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106728453-B |
| titleOfInvention | Pharmaceutical composition for regulating respiratory and nervous systems and application thereof |
| abstract | The invention discloses a pharmaceutical composition for regulating respiratory and nervous systems and application thereof. The pharmaceutical composition for regulating the respiratory system and the nervous system comprises 100-500 parts of rhizoma atractylodis, 50-250 parts of philippine violet herb, 100-500 parts of costustoot, 100-400 parts of folium artemisiae argyi and 20-80 parts of benzoin. The application is the application of the pharmaceutical composition for regulating the respiratory system and the nervous system in preparing the medicines for preventing/treating tracheitis and rhinitis. The invention solves the problems that the medicament for treating tracheitis and rhinitis in the current market generates larger smoke to cause lung discomfort due to unsatisfactory sublimation of medicinal components, the use formula is complicated, the price of the medicament formula material is too high, and the cost performance is too low. When the fumigant for treating tracheitis and rhinitis is used, the common electric heating mosquito-repellent incense box is opened, the mosquito-repellent incense tablet added with the fumigant for treating tracheitis and rhinitis is inserted, and after electricity is inserted, the effective components of the medicine are volatilized into the air through electric heating, so that the fumigant is favorably inhaled when a person falls asleep. |
| priorityDate | 2017-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.